Phoenix Molecular Designs to start clinical trials to battle deadly form of breast cancer

Written by Guest User

Jan. 08
2019

SAN FRANCISCO, Jan. 08 2019 - Phoenix Molecular Designs CEO Dr. Sandra Dunn joined Christine Corrado from Proactive Investors at the 11th Annual BioTech Showcase in San Francisco.

Watch the interview here

Guest User
Previous

Phoenix Molecular Designs Announces Collaboration To Develop Diagnostic for Triple-Negative Breast Cancer
Next

Phoenix Molecular Designs to Present at the Biotech Showcase 2019 Conference